HexaBody

WIPO WIPO 2012

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark HexaBody was filed as Word mark on 11/15/2012 at the World Intellectual Property Organization.

Trademark Details Last update: November 17, 2022

Trademark form Word mark
File reference 1145636
Register number VR201202115
Countries Australia em Iceland Japan South Korea Norway Singapore United States of America (USA) Switzerland China Russia
Base trademark DK No. VR 2012 02115, August 24, 2012
Application date November 15, 2012
Expiration date November 15, 2032

Trademark owner

Uppsalalaan 15
3584 CT Utrecht
NL

Trademark representatives

Axeltorv 2 1609 Copenhagen V DK

goods and services

01 Chemical, biochemical, biological, and biotechnological, preparations, especially antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases
05 Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases
42 Medical, scientific and biological research; especially research into antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments; including monovalent antibodies; derivatives or conjugates of any of these; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research; development and therapy with antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
45 Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicine

Trademark history

Date Document number Area Entry
November 15, 2022 2022/46 Gaz Extension
August 3, 2021 2021/36 Gaz US RAW: Partial Invalidation
November 24, 2016 2017/18 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 15, 2016 2016/29 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 20, 2014 2014/26 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 7, 2014 2014/11 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 3, 2014 2014/15 Gaz CH Rejection
January 17, 2014 2014/4 Gaz RU Rejection
December 19, 2013 2013/51 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 9, 2013 2013/50 Gaz CN Rejection
November 27, 2013 2013/49 Gaz EM Rejection
October 18, 2013 2013/43 Gaz KR Rejection
August 23, 2013 2013/35 Gaz NO Rejection
August 3, 2013 2013/32 Gaz SG Rejection
July 23, 2013 2013/37 Gaz IS Rejection
July 4, 2013 2013/27 Gaz JP Rejection
May 22, 2013 2013/21 Gaz AU Rejection
March 20, 2013 2013/16 Gaz US Rejection
November 15, 2012 2013/3 Gaz DK Registration

ID: 141145636